Back to companies

Translate Bio Inc: Overview

Get in touch about GlobalData Company reports

Contact the team or request a demo to find out how our data can drive your business forward

Select Item

Translate Bio Securities Corporation is developing drugs for the treatment of cystic fibrosis and inflammation. The company is headquartered in Boston, Massachusetts, the US.

 Gain a 360-degree view of Translate Bio Inc and make more informed decisions for your business Gain a 360-degree view of Translate Bio Inc and make more informed decisions for your business Register your interest
Headquarters United States of America
Address Suite 660, 84 State Street, Floor 6, Boston, Massachusetts, 02109
Industry Pharmaceuticals and Healthcare
Gain access to our premium signals and make informed decisions for your business Gain access to our premium signals and make informed decisions for your business Register your interest

Translate Bio Inc premium industry data and analytics

20+

Pipeline Drugs

Identify which of Translate Bio Inc’s products will be commercialized, helping you to better contend with shifting product portfolios, and allowing you to stay one step ahead of the market.

11+

Catalyst Calendar

Proactively evaluate Translate Bio Inc’s catalyst impacts to stay ahead of the competition & improve corporate planning. Bolster business development with timely opportunities.

4

Clinical Trials

Determine Translate Bio Inc go-to-market proposition and gain insight into the company’s clinical operations, recruitment, and trial strategy.

2

Insights

Remove risk and uncertainty, gain a competitive edge and secure actionable leads with access to company-related investigative journalist content.

1

Regulatory Milestones

Track drug and patent expiries along with geographies impacted.

Image for loader

Competitor Comparison

Key Parameters Translate Bio Inc Vertex Pharmaceuticals Inc Paratek Pharmaceuticals Inc AbelZeta Inc Gotham Therapeutics Corp
Headquarters United States of America United States of America United States of America United States of America United States of America
City Boston Boston King of Prussia Rockville New York City
State/Province Massachusetts Massachusetts Pennsylvania Maryland New York
No. of Employees - 5,400 268 - -
Entity Type Private Public Private Private Private
Benchmark the company against the market with exclusive information on key competitors Benchmark the company against the market with exclusive information on key competitors Register your interest
Executives
Name Position Board Since Age
Daniel Lynch Chairman Executive Board 2012 62
Ronald C. Renaud, Jr. Director; Chief Executive Officer Executive Board 2014 52
Brendan Smith Chief Financial Officer; Corporate Strategy Senior Management 2021 -
Paul Burgess Secretary; Chief Operating Officer; Chief Legal Officer Senior Management 2016 47
Frank DeRosa Chief Technology Officer Senior Management - -
Non Dignissim Eros Proin vel Convallis 2026 XY
Non Dignissim Eros Proin vel Convallis 2026 XY
Non Dignissim Eros Proin vel Convallis 2026 XY
Gain insight into Translate Bio Inc key executives to enhance your sales strategy Gain insight into Translate Bio Inc key executives to enhance your sales strategy Register your interest
Still looking?

Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.

Explorer

Access more premium companies when you subscribe to Explorer

Why are you leaving?